Urolithiasis on the ketogenic diet with concurrent topiramate or zonisamide therapy

Epilepsy Research

Volumn 90, Issue 1-2, 2010, Pages 151-156

  Paul, Elahna ^a   Conant, Kerry D ^a   Dunne, Irie E ^a   Pfeifer, Heidi H ^a   Lyczkowski, David A ^a   Linshaw, Michael A ^a   Thiele, Elizabeth A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Epilepsy; Ketogenic diet; Kidney stones; Topiramate; Zonisamide

Indexed keywords

TOPIRAMATE; ZONISAMIDE; ANTICONVULSIVE AGENT; FRUCTOSE; ISOXAZOLE DERIVATIVE;

ACIDURIA; ARTICLE; CHILD; CONTROLLED STUDY; CRYSTALLURIA; EPILEPSY; FEMALE; HEMATURIA; HUMAN; HYPERCALCIURIA; INFANT; KETOGENIC DIET; MAJOR CLINICAL STUDY; MALE; METABOLIC ACIDOSIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TREATMENT DURATION; UROLITHIASIS; ANALOGS AND DERIVATIVES; CHEMICALLY INDUCED; DIET THERAPY; MULTIMODALITY CANCER THERAPY; PRESCHOOL CHILD; RETROSPECTIVE STUDY;

ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; EPILEPSY; FEMALE; FRUCTOSE; HUMANS; INFANT; ISOXAZOLES; KETOGENIC DIET; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; UROLITHIASIS;

EID: 77953542262     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2010.04.005     Document Type: Article

References (36)

1. Freeman J.M., Vining E.P., Pillas D.J., Pyzik P.L., Casey J.C., Kelly L.M. The efficacy of the ketogenic diet-1998: a prospective evaluation of intervention in 150 children. Pediatrics 1998, 102:1358-1363.
2. Freeman J.M., Kossoff E.H., Hartman A.L. The ketogenic diet: one decade later. Pediatrics 2007, 119:535-543.
3. Furth S.L., Casey J.C., Pyzik P.L., Neu A.M., Docimo S.G., Vining E.P., Freeman J.M., Fivush B.A. Risk factors for urolithiasis in children on the ketogenic diet. Pediatr. Nephrol. 2000, 15:125-128.
4. Futagi Y., Otani K., Abe J. Growth suppression in children receiving acetazolamide with antiepileptic drugs. Pediatr. Neurol. 1996, 15:323-326.
5. Garris S.S., Oles K.S. Impact of topiramate on serum bicarbonate concentrations in adults. Ann. Pharmacother. 2005, 39:424-426.
6. Gillespie R.S., Stapleton F.B. Nephrolithiasis in children. Pediatr. Rev. 2004, 25:131-139.
7. Go T. Effect of antiepileptic drug polytherapy on crystalluria. Pediatr. Neurol. 2005, 32:113-115.
8. Goyal M., Grossberg R.I., O'Riordan M.A., Davis I.D. Urolithiasis with topiramate in nonambulatory children and young adults. Pediatr. Neurol. 2009, 40:289-294.
9. Groeper K., McCann M.E. Topiramate and metabolic acidosis: a case series and review of the literature. Paediatr. Anaesth. 2005, 15:167-170.
10. Hassan A.M., Keene D.L., Whiting S.E., Jacob P.J., Champagne J.R., Humphreys P. Ketogenic diet in the treatment of refractory epilepsy in childhood. Pediatr. Neurol. 1999, 21:548-552.
11. Inoue T., Kira R., Kaku Y., Ikeda K., Gondo K., Hara T. Renal tubular acidosis associated with zonisamide therapy. Epilepsia 2000, 41:1642-1644.
12. Kossoff E.H., Pyzik P.L., Furth S.L., Hladky H.D., Freeman J.M., Vining E.P. Kidney stones, carbonic anhydrase inhibitors, and the ketogenic diet. Epilepsia 2002, 43:1168-1171.
13. Kossoff E.H., Pyzik P.L., McGrogan J.R., Vining E.P., Freeman J.M. Efficacy of the ketogenic diet for infantile spasms. Pediatrics 2002, 109:780-783.
14. Lamb E.J., Stevens P.E., Nashef L. Topiramate increases biochemical risk of nephrolithiasis. Ann. Clin. Biochem. 2004, 41:166-169.
15. Leppik I.E., Willmore L.J., Homan R.W., Fromm G., Oommen K.J., Penry J.K., Sackellares J.C., Smith D.B., Lesser R.P., Wallace J.D., et al. Efficacy and safety of zonisamide: results of a multicenter study. Epilepsy Res. 1993, 14:165-173.
16. Leppik I.E. Zonisamide. Epilepsia 1999, 40(Suppl. 5):S23-29.
17. Lyczkowski D.A., Pfeifer H.H., Ghosh S., Thiele E.A. Safety and tolerability of the ketogenic diet in pediatric epilepsy: effects of valproate combination therapy. Epilepsia 2005, 46:1533-1538.
18. Maydell B.V., Wyllie E., Akhtar N., Kotagal P., Powaski K., Cook K., Weinstock A., Rothner A.D. Efficacy of the ketogenic diet in focal versus generalized seizures. Pediatr. Neurol. 2001, 25:208-212.
19. McNally M.A., Pyzik P.L., Rubenstein J.E., Hamdy R.F., Kossoff E.H. Empiric use of potassium citrate reduces kidney-stone incidence with the ketogenic diet. Pediatrics 2009, 124:e300-304.
20. Nordli D.R., Kuroda M.M., Carroll J., Koenigsberger D.Y., Hirsch L.J., Bruner H.J., Seidel W.T., De Vivo D.C. Experience with the ketogenic diet in infants. Pediatrics 2001, 108:129-133.
21. Philippi H., Boor R., Reitter B. Topiramate and metabolic acidosis in infants and toddlers. Epilepsia 2002, 43:744-747.
22. Preminger G.M., Sakhaee K., Pak C.Y. Alkali action on the urinary crystallization of calcium salts: contrasting responses to sodium citrate and potassium citrate. J. Urol. 1988, 139:240-242.
23. Purkerson J.M., Schwartz G.J. The role of carbonic anhydrases in renal physiology. Kidney Int. 2007, 71:103-115.
24. Sakhaee K., Nicar M., Hill K., Pak C.Y. Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone-forming salts. Kidney Int. 1983, 24:348-352.
25. Sampath A., Kossoff E.H., Furth S.L., Pyzik P.L., Vining E.P. Kidney stones and the ketogenic diet: risk factors and prevention. J. Child. Neurol. 2007, 22:375-378.
26. Sheth R.D. Metabolic concerns associated with antiepileptic medications. Neurology 2004, 63:S24-29.
27. Shorvon S.D. Safety of topiramate: adverse events and relationships to dosing. Epilepsia 1996, 37(Suppl. 2):S18-S22.
28. Srivastava T., Alon U.S. Pathophysiology of hypercalciuria in children. Pediatr. Nephrol. 2007, 22:1659-1673.
29. Takeoka M., Holmes G.L., Thiele E., Bourgeois B.F., Helmers S.L., Duffy F.H., Riviello J.J. Topiramate and metabolic acidosis in pediatric epilepsy. Epilepsia 2001, 42:387-392.
30. Takeoka M., Riviello J.J., Pfeifer H., Thiele E.A. Concomitant treatment with topiramate and ketogenic diet in pediatric epilepsy. Epilepsia 2002, 43:1072-1075.
31. Tawil R., Moxley R.T., Griggs R.C. Acetazolamide-induced nephrolithiasis: implications for treatment of neuromuscular disorders. Neurology 1993, 43:1105-1106.
32. Vaisleib I.I., Buchhalter J.R., Zupanc M.L. Ketogenic diet: outpatient initiation, without fluid, or caloric restrictions. Pediatr. Neurol. 2004, 31:198-202.
33. Warner B.W., LaGrange C.A., Tucker T., Bensalem-Owen M., Pais V.M. Induction of progressive profound hypocitraturia with increasing doses of topiramate. Urology 2008, 72:29-32. discussion 32-23.
34. Welch B.J., Graybeal D., Moe O.W., Maalouf N.M., Sakhaee K. Biochemical and stone-risk profiles with topiramate treatment. Am. J. Kidney Dis. 2006, 48:555-563.
35. Wiederkehr M., Krapf R. Metabolic and endocrine effects of metabolic acidosis in humans. Swiss Med. Wkly. 2001, 131:127-132.
36. Wroe S. Zonisamide and renal calculi in patients with epilepsy: how big an issue?. Curr. Med. Res. Opin. 2007, 23:1765-1773.